Organizers: 

Prof. Lina Badimon. Director, Cardiovascular Program-ICCC, Research Institute-Hospital de la Santa Creu i Sant Pau, IR-Sant Pau, CiberCV, Barcelona, Coordinator Cardiovascular Area-IIBSantPau, Professor National Scientific Research Council (CSIC), Barcelona, Spain

Dr. Carlos Zaragoza. Professor of Physiology and Cardiovascular Disease, University Hospital Ramon y Cajal/UFV School of Medicine, Madrid, Spain

Dr. Jamol Uzokov MD PhD. Cardiology – ESCI Young Research Council, Tashkent, Uzbekistan

Wednesday June 5, 2024

13:30h – 15:00h

SYMPOSIUM 2.1 | OBJECTIVE IMPROVING HEART FUNCTION - I
Chairpersons: Carlos Zaragoza (Madrid) & Raffaele Bugiardini (Bologna)

Tricuspide Valve disease. From anatomy to Function
José Luis Zamorano. Hospital Ramón y Cajal, Madrid, Spain

Prosthetic valve endocarditis: A clinical challenge
Bárbara Vidal. Hospital Clinic, Barcelona, Spain      

Comparison between endocardial and epicardial cardiac resynchronization in an experimental model of non-ischaemic cardiomyopathy 
José Maria Guerra. Hospital de Sant Pau, Barcelona, Spain

Abstract 1: Detecting congestion in heart failure patients with a four precordial electrodes set-up 
Johanneke Ten Broeke. University Medical Centre Utrecht, Utrecht, The Netherlands      

Abstract 2: New Preclinical Porcine Model of Tricuspid Regurgitation and Arrythmia for the Identification of Therapeutic Clinical Targets 
Claudia González-Cucharero. Ramón and Cajal Hospital, Madrid, Spain 
 
 15:00h – 15:30h

COFFEE BREAK

15:30h – 17:00h

SYMPOSIUM 2.2 | OBJECTIVE IMPROVING HEART FUNCTION - II
Chairpersons: Javier Bermejo (Madrid) & María Borrell (Barcelona)

Diabetic cardiomyopathy: a multisystem disease?
Genevieve Derumeaux. Paris, France

Improved Survival with Statin Treatment in Patients with Heart Failure after an Acute Coronary Syndrome 
Raffaele Bugiardini, Hospital Santa Orsola, Bolonia

BAbstract 1: lood immune and endothelial cell-released extracellular vesicle changes relate to COVID-19 mortality in hospitalised patients
Rosa Suades. IR-Hospital de la Santa Creu i Sant Pau, CIBERCV, Barcelona, Spain

Abstract 2: Targeting LDL aggregation with LRP1-based peptides reduces vascular lipid accumulation in a humanized lipoprotein profile-murine model 
Andrea Martínez. Hospital Santa Creu i Sant Pau, Barcelona, Spain

Abstract 3: Exploring the effects of mitochondriotropic antioxidant AntiOxCIN4 on cardiac metabolism of Western Diet-induced metabolic syndrome mice model
José Teixeira. University of Coimbra, Coimbra, Portugal
 

17:00h – 17:30h

OPENING CEREMONY

17:30h-18-30h

OPENING LECTURE

Epigenetics in Health and Disease: From Knowledge to Applications
Manel Esteller. Barcelona, Spain

18:30h - 19:30h

SATELLITE SYMPOSIUM FICYE | MEDITERRANEAN DIET, BEER AND HEALTH

**The Forum for Beer and Lifestyle Research (FICYE) is an entity that promotes research on beer and its relationship with lifestyle**

Ageing and nutrition: delaying chronological age by improving physiological age

Lina Badimon. Molecular Pathology and Therapeutics Department, IR-Hospital de Sant Pau, Barcelona, Spain

Beer, nutrition and immunity

Ascensión Marcos. Malaga Biomedical Research Institute and Nanomedicine Platform (IBIMA)

Gut microbiota, beer and diet

Isabel Moreno. Malaga Biomedical Research Institute and Nanomedicine Platform (IBIMA)

19:30-21.00h

BEER TASTING AND CHAMPIONS LEAGUE UNIVERSITIES

Thursday June 6, 2024 

9:00h – 10:30h

SYMPOSIUM 2.3 | CARDIOVASCULAR RISK FACTOR AND PRECLINICAL DISEASE – NEW APPROACHES FOR A HEALTHIER LIFE 
Chairpersons: Hendrik Nathoe (Utrecht) & Yvan Devaux (Luxembourg)

Diet in CVD prevention
Pepe López Miranda. Hospital Reina Sofia, Córdoba, Spain
 
Preclinical atherosclerosis: classic risk factor and/or inflammation
Guiomar Mendieta. Hospital Clinic, Barcelona, Spain

Mechanisms contributing to foam cell formation in the arterial wall as a source of new diagnostic and therapeutic opportunities in Atherosclerosis 
Vicente Llorente. CSIC, Barcelona, Spain
 
Abstract 1: Lp(a) and coronary artery calcium associates to a distinctive miRNA signature in patients with familial hypercholesterolemia and subclinical atherosclerosis
Rafael Escate. IR-Hospital de la Santa Creu i Sant Pau, CIBERCV, Barcelona, Spain

Abstract 2: Unveiling Cyclase-Associated Protein 1 (CAP1): A Novel Molecular Target in Endothelial Senescence-Linked Atherosclerosis
Ignacio Hernández. Francisco Vitoria University, Madrid, Spain
 
10:30h – 11:00h

COFFEE BREAK

11:00h – 12:30h

SYMPOSIUM 2.4 | IMAGING AND PATHOPHYSIOLOGY
Chairpersons: Geneviève Derumeaux (Paris) & Jamol Uzokov (Uzbekistan)

Intracardiac Fluid Dynamics. Physiological and Clinical Implications 
Javier Bermejo. Marañon, Madrid, Spain

Sport and the heart: too much of a good thing? 
María Sanz de la Garza. Hospital Clinic, Barcelona, Spain

Aorta
Artur Evangelista. Barcelona, Spain

Abstract 1: Early cardiac function in women with and without high-risk of preeclampsia
Johana Ullmo. Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

Abstract 2: Meteorin-like regulates the acute phase post-myocardial infarction
Artur Navarro. University of Barcelona, Barcelona, Spain
 
12:30h -13:30h

POSTER SESSION

13:30h - 14:30h

LUNCH

14:30h - 16:00h

SYMPOSIUM 2.5 | ACUTE CORONARY SYNDROMES- NOVEL MECHANISMS AND BETTER CLINICAL PRECISION
Chairpersons: Maria Borrell (Barcelona) & Artur Evangelista (Barcelona)

Inflammation, immunity and angiogenesis 
Lina Badimon. Hospital de Sant Pau, Barcelona, Spain

Microvascular dysfunction - Clinical evidences and need for therapies 
Filippo Crea. Hospital Gemelli, Roma, Italy 

CAC and clinical precision medicine 
Hendrik Nathoe. ESCI, Utrecht, The Netherlands

Abstract 1: Downregulation of Circulating Inflammation-Regulatory miRNAs and associated Pro-Inflammatory Profile in Out-of-Hospital Cardiac Arrest Patients with Poor Neurological Outcome
Ana Paula Dantas. University of Barcelona, Barcelona, Spain     

Abstract 2: Oral supplementation with a pure EPA ω-3 fatty acid reduces myocardial infarction-related-death and cardiac damage independent of its hypotriglyceridemic properties 
Sebastián Alcover. Hospital de La Santa Creu I Sant Pau, Barcelona, Spain

Friday, June 7 2024 

9:00h – 10:30h

SYMPOSIUM 2.6 | INNOVATION IN CARDIOLOGY
Chairpersons: Gemma Arderiu (Barcelona) & Charis Antoniades (London)

Non coding RNAs and Cardiology (15' + 5' discussion) 
Yvan Devauux. Luxembourg

Heart and brain: The LDL Receptor superfamily in neuronal cholesterol homeostasis 
María Borrell. IR-Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

Paramagnetic Nanoparticles: novel experimental approaches for local delivery in ACS
Carlos Zaragoza. Hospital Ramón y Cajal, Madrid

Abstract 1: Heart-brain crosstalk during myocardial infarction: changes in the brain following experimental myocardial infarction
Sergi Otero. IR-Hospital de la Santa Creu i Sant Pau, Barcelona, Spain    

Abstract 2: Cellular therapy based on human placental-derived mesenchymal stem cells as inducers of cardioprotective miRNAs following acute myocardial infarction
Nunzio Alcharani. Francisco de Vitoria University, Madrid, Spain    

10:30h – 11:00h

COFFEE BREAK

11:00h – 12:30h

SYMPOSIUM 2.7 | CARDIOVASCULAR ADVANCES  
Chairperson: Lina Badimon (Barcelona) & Carlos Zaragoza (Madrid)

Advanced therapies in ischemia: Can we promote functional angiogenesis
Gemma Arderiu. IR-HSCSP, Barcelona, Spain 

PVAT imaging 
Charis Antoniades. Oxford, United Kingdom

Artificial Intelligence and cardiovascular disease
Thomas Luscher. 

Abstract 1: Artificial Intelligence the NextGen Assistant for the healthcare 
Gulnora Abdieva. Samarkand State Medical University, Samarkand, Uzbekistan

Abstract 2: LRP5 and canonical WNT pathway in brain development 
Noelia Pimentel. IR-Hospital de la Santa Creu i Sant Pau, Barcelona, Spain    

12:30h - 14:00h

LUNCH

14:00h - 14:30h

EDITOR IN CHIEF EJCI / AWARD BEST ARTICLES EJC

14:30h - 15:30h

ESCI AWARDS

15:30h - 16:30h

ALBERT STRUYVENBERG MEDAL TO PROF. VALENTIN FUSTER AND LECTURE AWARD

16:30h - 17:00h

CLOSING